Masimo Corp (MASI):企業の財務・戦略的SWOT分析

◆英語タイトル:Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15882
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Masimo Corp (MASI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Masimo Corp (Masimo) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring technologies, medical devices and sensors to improve patient care. The company’s proprietary technologies include signal extraction technology (SET) that helps detect life threatening events; and rainbow SET platform. The products include pulse oximeters, patient monitors, central monitoring systems, specialty sensors, circuit boards, remote-alarms and monitoring solutions. Masimo markets products directly and also through a network of distributors and original equipment manufacturers (OEMs) to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities and consumers. The company operates in North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US.

Masimo Corp Key Recent Developments

Mar 25,2019 Masimo Announces FDA Clearance of the Rad-67 Pulse CO-Oximeter with Next Generation SpHb Spot-check Monitoring & rainbow DCI -mini Reusable Sensor
Mar 19,2019 St. Luke s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution
Mar 19,2019 St. Luke’s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution
Mar 04,2019 Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine Brain Function Monitoring

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Masimo Corp – Key Facts
Masimo Corp – Key Employees
Masimo Corp – Key Employee Biographies
Masimo Corp – Major Products and Services
Masimo Corp – History
Masimo Corp – Company Statement
Masimo Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Masimo Corp – Business Description
Geographical Segment: Asia and Australia
Performance
Geographical Segment: Middle East and Africa
Performance
Geographical Segment: North and South America (excluding United States)
Performance
Geographical Segment: United States
Performance
Masimo Corp – Corporate Strategy
Masimo Corp – SWOT Analysis
SWOT Analysis – Overview
Masimo Corp – Strengths
Masimo Corp – Weaknesses
Masimo Corp – Opportunities
Masimo Corp – Threats
Masimo Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Masimo Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Masimo Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Masimo Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 25, 2019: Masimo Announces FDA Clearance of the Rad-67 Pulse CO-Oximeter with Next Generation SpHb Spot-check Monitoring & rainbow DCI -mini Reusable Sensor
Mar 19, 2019: St. Luke s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution
Mar 19, 2019: St. Luke’s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution
Mar 04, 2019: Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine Brain Function Monitoring
Feb 26, 2019: Masimo announces fourth quarter and full year 2018 financial results
Feb 18, 2019: Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
Feb 11, 2019: Masimo Announces Doctella , a Secure Cloud-based Patient Engagement and Remote Care Automation Platform
Jan 09, 2019: Masimo Announces Select Preliminary Full-Year 2018 Financial Results and 2019 Outlook
Jan 07, 2019: Julie A. Shimer Ph.D. joins Masimo’s board of directors
Nov 12, 2018: International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Masimo Corp, Key Facts
Masimo Corp, Key Employees
Masimo Corp, Key Employee Biographies
Masimo Corp, Major Products and Services
Masimo Corp, History
Masimo Corp, Other Locations
Masimo Corp, Subsidiaries
Masimo Corp, Key Competitors
Masimo Corp, Ratios based on current share price
Masimo Corp, Annual Ratios
Masimo Corp, Annual Ratios (Cont...1)
Masimo Corp, Annual Ratios (Cont...2)
Masimo Corp, Interim Ratios
Masimo Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Masimo Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Masimo Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Masimo Corp, Performance Chart (2014 - 2018)
Masimo Corp, Ratio Charts
Masimo Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Masimo Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Masimo Corp (MASI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TAV Havalimanlari Holding A.S.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TAV Havalimanlari Holding A.S. …
  • Active Motif Inc:企業のM&A・提携動向(医療分野)
    Summary Active Motif Inc (Active Motif) is a biotechnology company that develops and delivers biological research tools and techniques which supports in protein analysis and biological function. The company’s products include antibodies, extracts, fluorescent dyes, kits, and recombinant proteins. It …
  • Medgenics Inc. (MDGN)(製薬・医療分野):企業M&A動向
    Summary Medgenics Inc. (Medgenics) is a biopharmaceutical company. The company develops unique technology platform for the express purpose of treating patients with rare genetic and orphan diseases. It offers pipeline products such as MDGN-201, MDGN-204, MDGN-205 and MDGN-206. Medgenics’s pipeline p …
  • ImevaX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops novel vaccines to prevent chronic and nosocomial infections. Its lead product candidate IMX101, an immune evasion vaccine, is indicated for the treatment of Helicobacter pylori. Its pipeline products include IMA101 mucosal adj …
  • Cleveland-Cliffs Inc:企業の戦略・SWOT・財務情報
    Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report Summary Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Chess Telecom:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Chess Telecom Mergers and Acqui …
  • Korea South-East Power Co., Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Korea South-East Power Co., Ltd. (KOSEP), a subsidiary of Korea Electric Power Corporation, is an energy utility that generates and markets electricity in Korea and internationally. It also focuses on the development of electric power resources. The company owns and operates thermal plants a …
  • Midea Group Co Ltd:戦略・SWOT・企業財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • London Broadcasting Company, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' London Broadcasting Company, In …
  • TRACON Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    TRACON Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TRACON Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Intrepid Potash, Inc.の企業概要及び財務/SWOT分析
    Intrepid Potash, Inc Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Intrepid Potash, Inc annual and quarterly forecasts made by stock market experts. The report also enables …
  • Shinhan Financial Group Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shinhan Financial Group Co., Lt …
  • Hampshire Trust Bank Plc:企業の戦略・SWOT・財務分析
    SummaryHampshire Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • SSAB AB:企業の戦略・SWOT・財務情報
    SSAB AB - Strategy, SWOT and Corporate Finance Report Summary SSAB AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Renaissance Learning, Inc.:企業の戦略的SWOT分析
    Renaissance Learning, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Agriterra Limited (AGTA):企業の財務及び戦略的SWOT分析
    Summary Agriterra Limited (Agriterra) is an agricultural investment company that invests in agricultural activities and sustainable development. The company’s products include beef, cocoa, maize and palm oil. It offers business in the fields of beef; that conducts cattle ranching, feedlot, abattoir …
  • Marubun Corporation:企業の戦略・SWOT・財務分析
    SummaryMarubun Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Marcegaglia SpA:企業の戦略・SWOT・財務情報
    Marcegaglia SpA - Strategy, SWOT and Corporate Finance Report Summary Marcegaglia SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CTI BioPharma Corp (CTIC):製薬・医療:M&Aディール及び事業提携情報
    Summary CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company, which acquires, develops, and commercializes targeted therapies for a range of blood-related cancers. The company’s lead product, Pixuvri (pixantrone) is an aza-anthracenedione used for the treatment of multiply relapsed or r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆